Cargando…
Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
BACKGROUND: Infants with respiratory-syncytial virus bronchiolitis hospitalization are more likely to develop wheezing and subsequent asthma. Reportedly, palivizumab prophylaxis effectively prevents respiratory-syncytial virus hospitalization in high-risk children—such as premature infants or infant...
Autores principales: | Fang, Li-Ching, Wang, Jen-Yu, Yu, Hsin-Hui, Wang, Li-Chieh, Chiang, Bor-Luen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510012/ https://www.ncbi.nlm.nih.gov/pubmed/37781666 http://dx.doi.org/10.1016/j.jacig.2023.100161 |
Ejemplares similares
-
Immunoprophylaxis of respiratory syncytial virus: global experience
por: Simoes, Eric AF
Publicado: (2002) -
Patient equity and respiratory syncytial virus Immunoprophylaxis
por: Cody Meissner, H.
Publicado: (2019) -
Seasonality in Respiratory Syncytial Virus Hospitalizations and Immunoprophylaxis
por: Kusma, Jennifer D., et al.
Publicado: (2023) -
Immunoprophylaxis against respiratory syncytial virus with palvizumab:
what is new?
por: Sáfadi, Marco Aurélio P.
Publicado: (2014) -
Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)